Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Pyxis Oncology Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Multiple Antibody-Drug Conjugates

Friday, March 19, 2021

Pyxis Oncology announced that it has entered into a worldwide license agreement with Pfizer Inc NYSEPFE for the development and commercialization of two antibodydrug conjugate ADC candidates and a license to Pfizers ADC technology platform enabling e...

Boston Pharmaceuticals Enters into Unique Multi-Year Out-License and Option Agreement with GSK for the Advancement of Multiple Pre-Phase 2 Programs

Friday, March 19, 2021

Boston Pharmaceuticals announced today a pioneering threeyear outlicense and option agreement with GlaxoSmithKline PLC LSENYSE GSK Boston Pharmaceuticals will become a preferred GSK partner for select prephase programs This new agreement builds on t...

M2GEN Announces New Collaboration with Merck to Advance Cancer Therapies

Thursday, March 18, 2021

MGEN a leading oncologyfocused data and informatics company announced today a significant new fiveyear agreement with Merck known as MSD outside the United States and Canada Under the terms of the agreement MGEN will provide valuable patientconsented...

Valence Discovery to Support Repare Therapeutics on AI-Enabled Drug Discovery in Precision Oncology

Thursday, March 18, 2021

Valence Discovery Valence an emerging leader in AIenabled drug design today announced it has entered into a drug discovery agreement with Repare Therapeutics a precision oncology company pioneering synthetic lethality to develop novel therapeutics fo...

WuXi Biologics to Acquire Biologics DS and DP Manufacturing Facilities from Pfizer China

Wednesday, March 17, 2021

WuXi Biologics a global company with leading openaccess biologics technology platforms announced that it has entered into an equity agreement with Pfizer China Pfizer to acquire its stateoftheart biologics manufacturing facilities as well as its la...

Nurix Therapeutics Announces Collaboration for the Discovery of Novel Drugs to Treat Pediatric Cancers

Wednesday, March 17, 2021

Nurix Therapeutics Inc a biopharmaceutical company developing targeted protein modulation drugs announced that it is part of a collaboration sponsored by Alexs Lemonade Stand Foundation ALSF a leading funder of pediatric cancer research

Takeda and IDT Collaborate on Johnson & Johnson COVID-19 Vaccine Manufacturing

Tuesday, March 16, 2021

Takeda Pharmaceutical Company Limited has just announced a mutual agreement with IDT Biologika GmbH IDT a development organization and contract manufacturing to utilize previously reserved IDT capacity for Takedas Dengue Vaccine Candidate TAK

Gilead and Merck Announce Agreement to Jointly Develop and Commercialize Long-Acting, Investigational Treatment Combinations

Tuesday, March 16, 2021

Gilead Sciences Incand Merck known as MSD outside the United States and Canada today announced that they have entered into an agreement to codevelop and cocommercialize longacting treatments in HIV that combine Gileads investigational capsid inhibito...

HepaTx, Namocell, and Takara Bio USA complete second phase of collaboration on single cell analysis for cell therapy to treat late-stage liver diseases

Monday, March 15, 2021

HepaTx Corporation Namocell Inc and Takara Bio USA Inc TBUSA announced successful completion of the second phase of their collaboration on single cell analysis of hepatocytelike cells iHeps differentiated from adipose tissuederived stromal cells ASCs...

PhaseBio Pharmaceuticals and BioVectra Enter into Supply Agreement to Support Development and Commercialization of Bentracimab

Friday, March 12, 2021

PhaseBio Pharmaceuticals Inc a clinicalstage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases and BioVectra Inc an innovative global contract development and manufacturing orga...